Pharmafile Logo
Pharmafocus logo
Advanced Search

Devolution and the new customers

August 1, 2005

Feature

Seretide helps GSK overcome production problems

August 1, 2005
Manufacturing and Production

News

Pfizer demands action after counterfeit Lipitor recovered in UK

July 29, 2005
Manufacturing and Production

Pfizer has demanded strict new anti-counterfeiting measures in the UK and across Europe following the discovery of fake versions of …

News

PCT mergers and commissioning changes to be decided in 2006

July 29, 2005

News

Schering-Plough’s new anti-fungal gains EMEA approval

July 29, 2005
Sales and Marketing

A new treatment for fungal infections has been given a positive opinion by the EMEA.Schering-Plough's Noxafil (posaconazole) is a novel …

News

New drug-resistant HIV treatment recommended

July 28, 2005
Sales and Marketing

Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been recommended for approval by the European regulator.The prevalence of …

News

Financial failings undermine improvements in NHS

July 28, 2005

News

Red Door bought by marketing services group

July 26, 2005
Medical Communications

News

NICE calls for more Alzheimer’s evidence to head off row

July 20, 2005

Manufacturers of three Alzheimer's treatments have been asked to supply more information to NICE to help decide whether or not …

News

PR group launched to counter pharma’s poor public image

July 20, 2005
Medical Communications

A new forum has been launched to promote dialogue between healthcare stakeholders and improve public perception of the pharma industry.The …

News

New 28-day pack for Cozaar launched

July 20, 2005
Sales and Marketing

A new 28-day pack of Merck Sharp & Dohme's top-selling hypertension treatment Cozaar has been launched in the UK.The 50mg …

News

Arixtra approved for new blood clot indication

July 20, 2005
Sales and Marketing Arixtra, GlaxoSmithKline

GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …

News

Iressa successor enters phase III

July 19, 2005
Research and Development, Sales and Marketing

AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …

News

AstraZeneca invests in novel cholesterol drugs

July 15, 2005
Research and Development

AstraZeneca is investing in a range of next generation cholesterol drugs which could reverse existing vascular disease in patients.The Anglo-Swedish …

News

Arimidex approved for post-surgery cancer prevention

July 13, 2005
Sales and Marketing

News

Getting inside the customer’s head

July 11, 2005
Sales and Marketing

Doctors are a diverse group of people. From GPs to specialists, with the more than 60 areas of medicine that …

Feature

Because they’re worth it?

July 11, 2005
Sales and Marketing

Feature

NHS tsar calls on clinicians to reassess clinical practice

July 11, 2005

The NHS tsar for primary care has called on clinicians to challenge the way they undertake clinical practice in order …

News

‘Virtual super surgeries’ the future for primary care

July 8, 2005

Plans to redesign the primary care landscape with the creation of purpose-built super surgeries are in many cases unfeasible, according …

News

GSK win for Euro RSCG Life MSC

July 7, 2005
Medical Communications

GlaxoSmithKline has awarded the pan-European launch of a major new neurological product to Euro RSCG Life MSC, following a three-way …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025